Max Solenthaler

3.8k total citations · 1 hit paper
29 papers, 2.7k citations indexed

About

Max Solenthaler is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Max Solenthaler has authored 29 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Genetics and 10 papers in Immunology. Recurrent topics in Max Solenthaler's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (4 papers). Max Solenthaler is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (4 papers). Max Solenthaler collaborates with scholars based in Switzerland, Germany and Italy. Max Solenthaler's co-authors include Miha Furlan, Bernhard Lämmle, Rodolfo Robles, Paul A. Kyrle, I. Scharrer, Giuseppe Remuzzi, Manuela Krause, U. Mittler, Miriam Galbusera and V. Aumann and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Max Solenthaler

29 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

1998 1.3k citations Miha Furlan, Rodolfo Robles et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Max Solenthaler	2.0k	1.6k	990	808	225	29	2.7k
Hernan Sabio	1.2k 0.6×	1.0k 0.6×	474 0.5×	449 0.6×	278 1.2×	55	2.2k
Carla Nester	2.5k 1.2×	948 0.6×	2.0k 2.0×	471 0.6×	314 1.4×	85	3.1k
R. John Looney	1.3k 0.7×	248 0.2×	186 0.2×	444 0.5×	236 1.0×	25	2.5k
Aruna Raghavachar	516 0.3×	1.5k 0.9×	84 0.1×	495 0.6×	357 1.6×	55	2.1k
Carlos M. DeCastro	492 0.2×	1.6k 1.0×	131 0.1×	644 0.8×	1.1k 4.9×	56	2.9k
Dana Tegzová	1.0k 0.5×	341 0.2×	166 0.2×	235 0.3×	111 0.5×	22	2.1k
RC Ash	723 0.4×	1.9k 1.2×	56 0.1×	434 0.5×	271 1.2×	32	2.4k
HJ Kolb	1.9k 0.9×	3.4k 2.1×	62 0.1×	792 1.0×	432 1.9×	30	4.4k
L Gugliotta	363 0.2×	957 0.6×	137 0.1×	622 0.8×	246 1.1×	66	1.4k
J P Vernant	638 0.3×	1.3k 0.8×	62 0.1×	365 0.5×	177 0.8×	49	2.0k

Countries citing papers authored by Max Solenthaler

Since Specialization

Citations

This map shows the geographic impact of Max Solenthaler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Solenthaler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Solenthaler more than expected).

Fields of papers citing papers by Max Solenthaler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Solenthaler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Solenthaler. The network helps show where Max Solenthaler may publish in the future.

Co-authorship network of co-authors of Max Solenthaler

This figure shows the co-authorship network connecting the top 25 collaborators of Max Solenthaler. A scholar is included among the top collaborators of Max Solenthaler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Solenthaler. Max Solenthaler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daskalakis, Michael, Anita Feller, Ulrike Bacher, et al.. (2019). Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries. Cancer Epidemiology. 59. 51–57. 10 indexed citations

Fernández, Paula, Max Solenthaler, Olivier Spertini, et al.. (2012). Using Digital RNA Counting and Flow Cytometry to Compare mRNA with Protein Expression in Acute Leukemias. PLoS ONE. 7(11). e49010–e49010. 13 indexed citations

Béné, Marie C., Thomas Nebe, Peter Bettelheim, et al.. (2011). Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 25(4). 567–574. 127 indexed citations

Colucci, Giuseppe, Tobias Silzle, & Max Solenthaler. (2011). Pyrazinamide‐induced sideroblastic anemia. American Journal of Hematology. 87(3). 305–305. 7 indexed citations

Leupin, Nicolas, Jan C. Schuller, Max Solenthaler, et al.. (2010). Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02). Leukemia & lymphoma. 51(4). 613–619. 6 indexed citations

Heimpel, H., et al.. (2009). Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia. Annals of Hematology. 88(10). 937–941. 8 indexed citations

Solenthaler, Max, et al.. (2007). Panzytopenie und Hämolyse - Diagnose, Differenzialdiagnose und Therapie der perniziösen Anämie. DMW - Deutsche Medizinische Wochenschrift. 132(27). 1469–1474. 1 indexed citations

Leupin, Nicolas, Jan C. Schuller, Max Solenthaler, et al.. (2007). The Combination of 2-CDA and Rituximab in Patients with Chronic Lymphocytic Leukemia (CLL): A Prospective Multicenter Phase II Trial (SAKK 34/02).. Blood. 110(11). 2057–2057. 1 indexed citations

Mühlematter, Dominique, V. Parlier, C Cabrol, et al.. (2005). Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases. Cancer Genetics and Cytogenetics. 160(2). 97–119. 13 indexed citations

10.

Hovinga, Johanna A. Kremer, Jan–Dirk Studt, Franziska Demarmels Biasiutti, et al.. (2004). Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.. PubMed. 89(3). 320–4. 48 indexed citations

11.

Gautschi, Oliver, et al.. (2003). Successful treatment of chemotherapy‐refractory Sézary syndrome with alemtuzumab (Campath‐1H). European Journal Of Haematology. 72(1). 61–63. 29 indexed citations

12.

Hovinga, Johanna A. Kremer, Max Solenthaler, & Jean‐François Dufour. (2003). Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis. European Journal of Gastroenterology & Hepatology. 15(10). 1141–1147. 6 indexed citations

13.

Calderoni, Antonello, Christian von Briel, Stefan Aebi, Max Solenthaler, & Daniel Betticher. (2002). Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial. Lung Cancer. 36(3). 321–326. 2 indexed citations

14.

Solenthaler, Max, et al.. (2000). Should Whole-Body Red Cell Mass Be Measured or Calculated?. Blood Cells Molecules and Diseases. 26(1). 25–31. 21 indexed citations

15.

Solenthaler, Max, et al.. (1999). Severe inclusion body β‐thalassaemia with haemolysis in a patient double heterozygous for β°‐thalassaemia and quadruplicated α‐globin gene arrangement of the anti‐4.2 type. British Journal of Haematology. 105(4). 1074–1080. 20 indexed citations

16.

Leibundgut, Elisabeth Oppliger, Martine Jotterand, V. Parlier, et al.. (1999). A novel BCR‐ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph‐chromosome and monosomy 7. British Journal of Haematology. 106(4). 1041–1044. 19 indexed citations

17.

Furlan, Miha, Rodolfo Robles, Miriam Galbusera, et al.. (1998). von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome. New England Journal of Medicine. 339(22). 1578–1584. 1254 indexed citations breakdown →

18.

Furlan, Miha, Rodolfo Robles, Max Solenthaler, & Bernhard Lämmle. (1998). Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura. Blood. 91(8). 2839–2846. 265 indexed citations

19.

Furlan, Miha, et al.. (1997). Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura. Blood. 89(9). 3097–3103. 417 indexed citations

20.

Solenthaler, Max, Manfred Ritter, RETO CANDINAS, Rolf Jenni, & Franz W. Amann. (1994). Arrhythmogenic right ventricular dysplasia in identical twins. The American Journal of Cardiology. 74(3). 303–304. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact